Clinical trial
Biological Efficacy of Clopidogrel After Implantation of Drug-eluting Stents…
NCT00298428 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00298428 |
|---|---|
| Title | Biological Efficacy of Clopidogrel After Implantation of Drug-eluting Stents (SPACE) |
| Official title | Biological Efficacy of Clopidogrel 600 mg Loading Dose Followed by 75 mg Maintenance Dose After Implantation of Drug-eluting Stents in Patients With Diabetes Mellitus or Metabolic Syndrome (SPACE) |
| Acronym | SPACE |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Atherosclerosis, Diabetes Mellitus, Metabolic Syndrome X |
| Intervention type | Procedure |
| Interventions | blood samples |
| Enrollment | 159 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Mar 2, 2006 |
| Last update posted | Sep 26, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: